Roots Analysis has done a detailed report on Oral Solid Dosage Manufacturing Market, covering key aspects of the industry and identifying future growth opportunities.

Key Market Insights
 Presently, nearly 570 companies, across the globe, offer services for the manufacturing of different types of oral solids.
 Nearly 50% of the aforementioned service providers are based in the Asia-Pacific region, followed by the players located in Europe (29%).
 The oral solid dosage contract manufacturing industry is dominated by the presence of mid-sized players (51-200 employees), which represent around 40% of the total contract manufacturers.
 Nearly 15% players claim to act as one-stop shops, offering services, ranging from formulation and process development to the analytical testing, scale-up, and packaging of oral solids.
 Over 85 expansion initiatives were undertaken in the period 2018-2022; close to 50% of the total number of expansions were undertaken in North America.
 More than 50% of the annual, global oral solid dosage contract manufacturing capacity (in terms of number of finished dosages) belongs to very large players with over 10,000 employees.
 Nearly 45% of the global outsourced commercial demand is anticipated to be driven by oral solids intended to target oncological indications.
 The oral solid dosage contract manufacturing market is likely to grow at a CAGR of ~5%, till 2035; the projected opportunity is likely to distributed across various dosage types, primary packaging, company sizes, scales of operation, therapeutic areas and geographical areas.
 North America and Europe are anticipated to capture around 85% of the market share, till 2035.
 In terms of type of finished dosage form, the current market is driven by tablet manufacturing (close to 60%); this trend is unlikely to change in the foreseen future.

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Type of Dosage Forms
3.3. Overview of Oral Solid Dosage Forms
3.4. Overview of Oral Solid Contract Manufacturing
3.5. Future Perspectives

4. ORAL SOLID DOSAGE MANUFACTURING ORGANIZATIONS (CMOs):
MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Oral Solid Dosage CMOs: List of Companies

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Company Competitiveness Analysis: Oral Solid Dosage Contract Manufacturers in North America
5.5. Company Competitiveness Analysis: Oral Solid Dosage Contract Manufacturers based in Europe
5.6. Company Competitiveness Analysis: Oral Solid Contract Manufacturers based in Asia-Pacific and Rest of the World
5.7. Company Competitiveness Analysis of Oral Solid Dosage Contract Manufacturers: Competitiveness Score of Top Service Providers

6. REGIONAL CAPABILITY ANALYSIS
6.1. Chapter Overview
6.2. Key Assumptions and Methodology
6.3. Overall Landscape of Oral Solid Dosage Contract Manufacturing Facilities
6.4. Oral Solid Dosage Contract Manufacturers in North America
6.5. Oral Solid Dosage Contract Manufacturers in Europe
6.6. Oral Solid Dosage Contract Manufacturers in Asia-Pacific and Rest of the World

7. COMPANY PROFILES
7.1. Chapter Overview

7.2. Oral Solid Dosage Contract Manufacturing Service Providers: North America
7.2.1. Alcami
7.2.1.1. Company Overview
7.2.1.2. Service Portfolio
7.2.1.2.1. Manufacturing Capabilities and Facilities
7.2.1.3. Recent Developments and Future Outlook

7.2.2. Cambrex
7.2.3. Catalent

7.3. Oral Solid Dosage Contract Manufacturing Service Providers: Europe
7.3.1. Aenova
7.3.2. Almac
7.3.3. Lonza

7.4. Oral Solid Dosage Contract Manufacturing Service Providers: Asia-Pacific and Rest of the World
7.4.1. Hetero Drugs
7.4.2. Ind-Swift Laboratories
7.4.3. Rubicon Research

8. MAKE VERSUS BUY DECISION FRAMEWORK
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Oral Solid Dosage Manufacturers: Make versus Buy Decision Making
8.4. Concluding Remarks

9. RECENT EXPANSIONS
9.1. Chapter Overview
9.2. Oral Solid Dosage Contract Manufacturers: Recent Expansions

10. CAPACITY ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions and Methodology

11. DEMAND ANALYSIS
11.1. Chapter Overview
11.2. Key Assumptions and Methodology
11.3. Overall Annual Demand for Oral Solids, 2023-2035

11.4. Annual Outsourced Commercial Demand for Oral Solids, 2023-2035
11.5. Annual Outsourced Clinical Demand for Oral Solids, 2023-2035
11.6. Correlation between Annual Demand and Capacity

12. TOTAL COST OF OWNERSHIP FOR ORAL SOLID DOSAGE CONTRACT MANUFACTURING ORGANIZATIONS
12.1. Chapter Overview
12.2. Key Parameters
12.3. Assumptions and Methodology
12.4. Sample Dataset for the Estimation of Total Cost of Ownership
12.5. Total Cost of Ownership for Oral Solid Dosage Contract Manufacturing Organizations, Y0-Y20
12.6. Total Cost of Ownership for Oral Solid Dosage Contract Manufacturing Organizations: Analysis by CapEx and OpEx, Y0 and Y20
12.7. Concluding Remarks

13. REGULATORY LANDSCAPE FOR ORAL SOLID DOSAGE CONTRACT MANUFACTURERS
13.1. Chapter Overview
13.2. Regulatory Guidelines in North America
13.3. Regulatory Guidelines in Europe
13.4. Regulatory Guidelines in Asia-Pacific and Rest of the World
13.5. Oral Solid Dosage CMOs: Information on Approval from Various Regulatory Authorities
13.6. Bubble Analysis: Regional Regulatory Summary

14. CASE STUDY ON TASTE MASKING SERVICES AND TECHNOLOGIES: MARKET LANDSCAPE
14.1. Chapter Overview
14.2. Taste Masking and Taste Assessment Service Providers
14.3. Taste Masking and Taste Assessment Services: Overall Market Landscape

15. CASE STUDY ON BIOAVAILABILITY ENHANCEMENT TECHNOLOGIES: MARKET LANDSCAPE
15.1. Chapter Overview
15.2. Bioavailability Enhancement Service Providers: Overall Market Landscape

16. MARKET FORECAST
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions

17. EXECUTIVE INSIGHTS

18. CONCLUDING REMARKS

19. APPENDIX 1: TABULATED DATA
20. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link
www.rootsanalysis.com/reports/oral-solid-dosage-manufacturing-market.html

News article
Global Gene Switch Market

Learn from experts: do you know about these emerging industry trends?
Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities
Medical Device Coatings and Modification Technologies

Learn from our recently published whitepaper: —
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
[email protected]

The “Conjugation and Labeling Services Market: Focus on Protein Labeling, Peptide Labeling, Small Molecule Conjugation and Antibody Conjugation, 2023-2035” report features an extensive study of the current market landscape, market size and the likely future potential of the conjugation and labeling services market, during the forecast period.

Key Inclusions
 An executive summary of the insights captured during our research. It offers a high-level view on the current state of conjugation and labeling services market and its likely evolution in the mid-long term.
 A general overview of conjugation and labeling of biomolecules, highlighting the various advantages of biomolecule conjugation and labeling. It also provides details on the different types of biomolecular conjugates and labels. Further, the chapter concludes with a discussion on various applications of the conjugated and labeled biomolecules in the biotechnology and pharmaceutical industry.
 A detailed assessment of the overall market landscape of the companies offering conjugation and labeling services, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of molecule(s) supported (proteins, peptides, small molecules, antibodies and other molecules), type of molecular conjugate(s) / label(s) (polymers, haptens, enzymes, fluorescent tags, FRET pairs, quantum dots, carrier proteins, streptavidin, chelators, bead coupling / particle conjugates, isotopes, photoreactives and other molecular conjugates / labels) and conjugation service(s) offered.
 A company competitiveness analysis of conjugation and labeling service providers based on company strength (in terms of years of experience and company size) and service strength (in terms of type of molecule(s) supported, type of molecular conjugate(s) / label(s) and conjugation service(s) offered).
 Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering conjugation and labeling services, located across North America, Europe and Asia-Pacific. Each profile features a brief overview of the company, recent developments and an informed future outlook.
 A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2018, covering acquisitions, service agreements, product development agreements, technology licensing agreements, and other relevant agreements.
 An in-depth analysis of recent events (webinars / conferences / seminars / meetings / symposiums / summits) that were organized for stakeholders in the bioconjugation domain, based on several relevant parameters, such as year of event, event platform, type of event, geography, key focus areas, most active event organizers, active industry and non-industry players (in terms of number of speakers), seniority level of event speakers and geographical mapping of upcoming events.
 A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, featuring a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall conjugation and labeling services market.

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
 Type of Molecule
 Proteins
 Peptides
 Small Molecules
 Antibodies
 Other Molecules

 Type of Molecular Conjugate / Label
 Polymers
 Haptens
 Enzymes
 Fluorescent Tags
 Bead Coupling / Particle Conjugates
 Quantum Dots
 Isotopes
 Other Molecular Conjugates / Labels

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

Frequently Asked Questions
 What is the global market size of antibody conjugation services market?
 Which are the leading companies in the antibody conjugation services market?
 How many companies offer peptide conjugation services?
 What percentage of service providers are engaged in offering conjugation and labeling services with both fluorescent tags and enzymes?
 How many service providers offer services related to antibody-enzyme bioconjugation?
 What are the major factors driving the conjugation and labeling services market?
 What are the leading market segments in the conjugation and labeling services market?
 Which region captures the highest share in the conjugation and labeling services market?
 What is the likely growth rate (CAGR) for conjugation and labeling services market?

For additional details, please visit www.rootsanalysis.com/reports/conjugation-and-labeling-services-market.html

News article
Bioavailability Enhancement Services Market

Learn from experts: do you know about these emerging industry trends?
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Novel Cell Cytometers: Need of the Hour

Learn from our recently published whitepaper: —
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting — the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
[email protected]

As per report by Roots Analysis — due to the technical and operational challenges associated with the in-house viral clearance and testing procedures, players in the biopharmaceutical industry are increasingly relying on the viral clearance and testing service providers

Roots Analysis has announced the addition of “Viral Clearance and Testing Services Market, 2023 – 2035” report to its list of offerings

The report features an extensive study on the current landscape and the likely future potential of viral clearance market, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. In addition to other elements, the study includes:

 A general overview of the viral clearance and testing studies, highlighting details on viral contamination in biologics and the need for viral clearance and testing.
 A detailed assessment of the overall market landscape of the companies offering viral clearance and testing services, based on several relevant parameters.
 A detailed competitiveness analysis of viral clearance and testing service providers based in North America, Europe and Asia-Pacific.
 Tabulated profiles of key players based in North America, Europe and Asia-Pacific that are engaged in providing services related to viral clearance and testing (shortlisted based on strength of service portfolio).
 An in-depth analysis of various patents that have been filed / granted for viral clearance and testing, since 2017, based on various relevant parameters.
 A detailed analysis of recent developments taking place in this domain.

The financial opportunity within the viral clearance and testing services market has been analyzed across the following segments:

 Scale of Operation
 Discovery Phase
 Preclinical Phase
 Clinical Phase

 Method of Viral Clearance testing
 Viral Detection
 Viral Inactivation
 Viral Removal

 End-User
 Biotechnology and Pharmaceutical Companies
 Academic / Research Institutes

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Rest of the World

Key Companies covered in the report
 Charles River Laboratories
 Eurofins Scientific
 Microbac Laboratories
 Nelson Labs
 Pall Corporation
 Syngene International
 Texcell

To view more details on this report, click on the link
www.rootsanalysis.com/reports/viral-clearance-and-testing-services-market.html

News article
Non-viral Transfection Reagents and Systems Market

Learn from experts: do you know about these emerging industry trends?
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Novel Cell Cytometers: Need of the Hour

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting — the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
[email protected]

Roots Analysis has done a detailed study on Dental 3D Printing Market, 2023 – 2035, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

Key Market Insights
 Presently, around 230 dental 3D printers are available for use across wide range of dental applications; majority of these devices print crowns, bridges, dentures and working models
 A myriad of printing technologies are currently being used by dental 3D printer manufacturers; majority of the dental 3D printers use resins as printing material
 The current market landscape is highly fragmented, featuring the presence of both new entrants and established players across key geographical regions; majority of these players are based in Europe and Asia-Pacific
 In pursuit of gaining a competitive edge, developers are making an active effort to incorporate advanced technologies into their respective portfolios of dental 3D printers and comply with evolving industry needs
 The growing interest of stakeholders is also evident from the rise in partnership activity; in fact, majority of the intracontinental agreements were signed by companies based in North America
 The rising interest of various stakeholders in dental 3D printing and associated technologies has led to an increase in research, and subsequently, the expansion of intellectual capital in this domain
 Cost is a key determinant of the acceptance and adoption of 3D printers in the dental industry; pricing strategy matrix is likely to assist players in evaluating the competitive market prices for their offerings
 The dental 3D printing market is expected to grow at a CAGR of 14.2% till 2035; the projected opportunity is likely to be well distributed across various market segments

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Dental 3D Printing
3.3. Dental 3D Printing Technologies
3.4. Applications of 3D Printing in Dental Industry
3.5. Advantages and Limitations Associated with Dental 3D Printing
3.6. Future Perspectives

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Dental 3D Printers: Overall Market Landscape
4.3. Dental 3D Printer Manufacturers: Developer Landscape

5. PRODUCT COMPETITIVE ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Product Competitiveness Analysis: Dental 3D Printers

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. 3D Systems
6.2.1. Company Overview
6.2.2. Dental 3D Printer Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Asiga
6.4. BEGO
6.5. Carbon
6.6. Digital Wax Systems (DWS)
6.7. Formlabs
6.8. Prodways
6.9. Rapid Shape
6.10. SprintRay
6.11. Stratasys

7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models
7.3. Dental 3D Printing: List of Partnerships and Collaborations
8. PATENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Dental 3D Printing: Patent Analysis
8.4. Dental 3D Printing: Patent Benchmarking Analysis
8.5. Dental 3D Printing: Patent Valuation
8.6. Leading Patents by Number of Citations

9. BOWMAN CLOCK PRICING
9.1. Chapter Overview
9.2. Bowman Strategy Clock
9.3. Roots Analysis Framework

10. MARKET FORECAST AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Global Dental 3D Printing Market, 2023-2035

11. CONCLUDING REMARKS

12. APPENDIX 1: TABULATED DATA
12.1. Chapter Overview
12.2. 3DTech
12.2.1. Company Snapshot
12.3. Totustec

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Get more details on the Dental 3D Printing Market report www.rootsanalysis.com/reports/dental-3d-printing-market.html

You may also be interested in the following titles:
DNA Encoded Libraries
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Exosome Therapeutics Market
Roots Analysis Consulting — the preferred research partner for global firms

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
[email protected]

Driven by the growing demand of medical devices, coupled with unique coating needs for each type of medical device, an increasing number of developers are leveraging the technical expertise of coating providers in this industry

Roots Analysis has announced the addition of “Medical Device Coating Market, 2023-2035” report to its list of offerings. The report features an extensive study on the current market landscape, offering an informed opinion on the likely adoption of the medical device coatings and surface modification technologies in the healthcare industry, in the mid to long term. The study underlines an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

Amongst other elements, the report includes:
 A detailed executive summary of the insights captured during our research.
 A detailed assessment of the current market landscape of medical device coating providers.
 Detailed competitiveness analysis of various medical device coating providers.
 A detailed assessment of the overall market landscape of medical device surface modification technologies and coating solutions.
 Detailed product competitiveness analysis of the various surface modification technologies and coating solutions.
 Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering medical device coatings.
 An insightful analysis of the recent partnerships that have been inked within the surface modification technologies and coating solutions industry, since 2018.
 An insightful analysis of the leading medical device coating providers, considering the affiliated factors, key drivers, and challenges under the PESTLE framework.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Type of Devices Coated
 Class I Medical Devices
 Class II Medical Devices
 Class III Medical Devices
 Type of Coating Material
 Polymer Coatings
 Metal Coatings
 Other Coatings
 Company Size
 Very Small
 Small
 Mid-sized
 Large
 Very Large
 Key Geographical Region
 North America
 Europe
 Asia
 Rest of the World

Key companies covered in the report
 Advanced Coating
 Biocoat
 Evonik
 Formacoat
 Harland Medical Systems
 Para-Coat Technologies
 Specialty Coating Systems
 SurModics
 TUA Systems

To view more details on this report, click on the link:
www.rootsanalysis.com/reports/medical-device-coatings-market.html

You may also be interested in the following titles:
Pharmaceutical Polymers / Medical Polymers Market
Novel Cell Cytometers: Need of the Hour
Global Gene Switch Market
Roots Analysis Consulting — the preferred research partner for global firms

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
[email protected]

Roots Analysis has done a detailed study on Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market, covering important aspects of the industry and identifying key future growth opportunities.

Key Market Insights
 Presently, more than 70 players across the globe claim to offer deep learning technologies for potential applications across various steps of drug discovery and development process
 Majority (70%) of the stakeholders employ proprietary deep learning-based technologies in drug discovery to offer big data analysis
 Nearly 50% of the deep learning-based diagnostic providers are based in North America; most such players offer technologies for use across medical imaging and medical diagnosis related applications
 Around 70% of the players engaged in offering deep learning solutions for diagnostics have been established post-2011; majority of the players offer solutions focused on oncological disorders
 Foreseeing the lucrative potential, a large number of players have made investments worth over USD 15 billion, across 210 funding instances, to advance the initiatives undertaken by industry stakeholders
 Over the past few years, more than 704,000 patients have been recruited / enrolled in clinical trials registered for deep learning-based solutions / diagnostics across different geographies
 Our proprietary benchmarking analysis, based on a variety of parameters, indicates the leading start-ups / small firms that are spearheading innovation in this domain
 Some players have managed to establish strong competitive positions; in the near future, we expect multiple acquisitions to take place wherein the relative valuation of a firm is likely to be a key determinant
 Increasing adoption of deep learning technologies in the life sciences and healthcare industry is anticipated to create profitable business opportunities for the technology developers
 The market opportunity associated with deep learning in drug discovery is expected to witness an annualized growth rate of 23% over the coming 12 years
 In the long term, the opportunity for deep learning in diagnostics is projected to grow exponentially; the market is likely to be well distributed across various therapeutic areas and geographical regions

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Humans, Machines and Intelligence
3.2. The Science of Learning
3.3. The Big Data Revolution
3.4. Deep Learning in Healthcare
3.5. Concluding Remarks

4. MARKET OVERVIEW: DEEP LEARNING IN DRUG DISCOVERY
4.1. Chapter Overview
4.2. Deep Learning in Drug Discovery: Overall Market Landscape of Service / Technology Providers

5. MARKET OVERVIEW: DEEP LEARNING IN DIAGNOSTICS
5.1. Chapter Overview
5.2. Deep Learning in Diagnostics: Overall Market Landscape of Service / Technology Providers

6. COMPANY PROFILES
6.2. Aegicare
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. Aiforia Technologies
6.4. Ardigen
6.5. Berg
6.6. Google
6.7. Huawei
6.8. Merative
6.9. Nference
6.10. Nvidia
6.11. Owkin
6.12. Phenomic AI
6.13. Pixel AI

7. PORTER’S FIVE FORCES ANALYSIS
7.1. Chapter Overview
7.2. Methodology and Assumptions
7.3. Key Parameters
7.4. Concluding Remarks

8. CLINICAL TRIAL ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3 Deep Learning Market: Clinical Trial Analysis

9. FUNDING AND INVESTMENT ANALYSIS
9.1. Chapter Overview
9.2. Types of Funding
9.3. Deep Learning Market: Funding and Investment Analysis

10. START-UP HEALTH INDEXING
10.1. Chapter Overview
10.2. Start-ups Focused on Deep Learning in Drug Discovery
10.3. Benchmarking Analysis of Start-ups Focused on Deep Learning in Drug Discovery
10.4. Start-ups Focused on Deep Learning in Diagnostics
10.5. Benchmarking Analysis of Start-ups Focused on Deep Learning in Diagnostics
10.5.1. Analysis by Focus Area

11. COMPANY VALUATION ANALYSIS
11.1. Chapter Overview
11.2. Company Valuation Analysis: Key Parameters
11.3. Methodology
11.4. Company Valuation Analysis: Roots Analysis Proprietary Scores

12. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DRUG DISCOVERY
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Overall Deep Learning in Drug Discovery Market, 2023-2035

13. MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DIAGNOSTICS
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Overall Deep Learning in Diagnostics Market, 2023-2035

14. DEEP LEARNING IN HEALTHCARE: EXPERT INSIGHTS

15. CONCLUDING REMARKS

16. INTERVIEW TRANSCRIPTS
16.1. Chapter Overview
16.2. Nucleai
16.3. Mediwhale
16.4. Arterys
16.5. AlgoSurg
16.6. ContextVision
16.7. Advenio Technosys
16.8. Arterys
16.9. Arya.ai

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link
www.rootsanalysis.com/reports/view_document/deep-learning-in-drug-discovery-market/156.html

You may also be interested in the following titles:
Decentralized Clinical Trials / Virtual Clinical Trials Market
Exploring AI-based Digital Pathology
Medical Device Coatings Market
Roots Analysis Consulting — the preferred research partner for global firms

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
[email protected]

Drawbacks of conventional parenteral drug delivery systems have paved the way for the development of improved techniques and better drug administration devices.

Over the past few years, there has been an evident shift towards the self-administration of drugs / therapies. These self-injection devices facilitate the effective administration of therapeutics for the treatment of emergency and chronic conditions.

The “Autoinjectors: IP Landscape” report features an extensive study of the key intellectual property (IP) documents (featuring granted autoinjectors patents, patent applications and other documents), describing the various types of autoinjectors and their components that offer safety features and patient compliance during self-administration of drugs. The insights generated in this report have been presented across two deliverables, a MS Excel workbook and a MS PowerPoint deck, summarizing the ongoing activity in this domain.

The research includes detailed profiles of 10+ key players (listed below); the profiles feature an overview of the developer, its financial information (if available), product portfolio (under development / marketed) recent developments and an informed future outlook.
 Bristol Myers Squibb
 Sanofi
 Ypsomed
 Novo Nordisk
 Owen Mumford
 Becton Dickinson
 Janssen
 SHL Group
 Amgen
 Aptar Pharma
 UCB
 Meridian Medical
 Eli Lilly
 PHC technologies
 Ascendis Pharma

Table of Contents

EXCEL DELIVERABLE

1. RESEARCH NOTES

2. SUMMARY DASHBOARD

3. OVERALL INTELLECTUAL PROPERTY LANDSCAPE DATASET

4. PRIOR ART SEARCH EXPRESSIONS (KEYWORD ANALYSIS)

5. PATENT APPLICATIONS DATASET

6. GRANTED PATENTS DATASET

7. CLAIMS ANALYSIS
8. KEY APPLICANTS ANALYSIS

9. CPC ANALYSIS

10. APPENDIX I: PIVOT TABLES

11. APPENDIX II: COUNTRY / GEOGRAPHY CODES

12. APPENDIX III: INNOVATION CATEGORIES

POWERPOINT DELIVERABLE

1. CONTEXT
2. PROJECT APPROACH

3. PROJECT OBJECTIVES

4. EXECUTIVE SUMMARY

5. INTRODUCTION

6. OVERALL INTELLECTUAL PROPERTY LANDSCAPE

7. KEY PRIOR ART SEARCH EXPRESSIONS

8. INTELLECTUAL PROPERTY VALUATION ANALYSIS

9. ANALYSIS OF PATENT APPLICATIONS

10. ANALYSIS OF GRANTED PATENTS

11. KEY APPLICANTS

12. POCKETS OF INNOVATION AND WHITE SPACES

13. FUTURE OUTLOOK

14. APPENDICES

To view more details on this report, click on the link
www.rootsanalysis.com/reports/autoinjectors-intellectual-property-landscape.html

You may also be interested in the following titles:
Global Antibiotics Market

Pharmaceutical Polymers / Medical Polymers Market
Global Gene Switch Market

Cell Therapy Media Market, Cell Therapy Kits Market, Cell Therapy Reagents Market and Cell Therapy Surface Market

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
[email protected]

The “Pharmaceutical Polymers / Medical Polymers Market, 2023-2035” report features an extensive study of the current market landscape and future opportunity for pharmaceutical polymer / medical polymer manufacturers.

Key Inclusions
 An executive summary of the insights captured during our research. It offers a high-level view on the current state of pharmaceutical polymers / medical polymers market and its likely evolution in the mid-long term.
 A general overview of polymers, their historical background and properties, such as physical, chemical and mechanical, along with information on different types of polymers (based on a variety of parameters) and their applications in the pharmaceutical / medical domain.
 A detailed assessment of the overall landscape of pharmaceutical polymer / medical manufacturers, based on several relevant parameters, such as year of establishment, company size (based on the number of employees), location of headquarters, source of polymer (natural, semi-synthetic and synthetic), composition of polymer (amino-based polymer, polysaccharide-based polymer, polyester, cellulose-based polymer, polyolefin, polyether, acrylic polymer, vinyl-based polymer, styrene-based polymer, plastic, siloxane-based polymer, sulphur-based polymer, rubber, amide-based polymer, imine-based polymer, fluorocarbon-based polymer, anhydride-based polymer, oxazoline-based polymer and other polymers), type of polymer (thermoplastic polymers, elastomers, thermoset polymers and fibers), and area of application (excipients, drug delivery devices / drug delivery device components, packaging, diagnostic devices / reagents / equipments, surgical instruments / solutions / equipments, connected devices, wound dressing, dental devices, implants, tissue regeneration, medical device coating, fluid handling system, purification and others).
 A comprehensive competitiveness analysis of pharmaceutical polymer / medical polymer manufacturers based in North America, Europe, and Asia-Pacific and Rest of world, presenting a comparison based on supplier power (in terms of number of years of experience), service portfolio strength (in terms of source of polymer, number of types of polymers, number of application area and biodegradability of polymers) and number of unique compositions of polymer.
 Elaborate profiles of key players engaged in the manufacturing of pharmaceutical polymers / medical polymers (shortlisted based on proprietary criteria), across North America, Europe, and Asia-Pacific and rest of world, featuring a brief overview of the company, details related to its portfolio for pharmaceutical polymers / medical polymers, recent developments and an informed future outlook.
 An analysis of partnerships and collaborations, inked between pharmaceutical polymers / medical polymers manufacturers, since 2019, based on several relevant parameters, such as year of partnership, type of partnership, composition of polymer, type of polymer, area of application, type of partner, most active players (in terms of number of partnerships) and region.
 An insightful analysis of leading pharmaceutical polymer / medical polymer manufacturers, by considering affiliated factors, key drivers and challenges under the DELT framework, thereby, highlighting the relative effect of each factor of DELT parameter on pharmaceutical polymer / medical polymer manufacturers market.
 A case study on recent and emerging trends related to pharmaceutical polymers / medical polymers, highlighting information on novel polymers (such as biodegradable polymers and smart polymers) and polymer recycling initiatives adopted by manufacturers for maintaining a sustainable environment.

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

 Type of Polymer
 Thermoplastic Polymers
 Elastomers
 Thermoset Polymers
 Others

 Area of Application
 Medical Devices
 Excipients
 Packaging
 Others

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa

Key Questions Answered
 Who are the key players engaged in manufacturing pharmaceutical polymers / medical polymers?
 Which are the most commonly used polymers in the pharmaceutical domain?
 What are the uses of pharmaceutical polymers / medical polymers?
 What is the relative competitiveness of pharmaceutical polymer / medical polymer manufacturers?
 What types of partnership models are commonly adopted by stakeholders in this industry?
 What are the key market trends and driving factors that are likely to impact this market?
 What is the current / likely future market size of pharmaceutical polymers / medical polymers market?
 Which type of polymer is likely to have the largest share in the pharmaceutical polymers / medical polymers market?
 Which region captures the largest share of the pharmaceutical polymers / medical polymers market?

To view more details on this report, click on the link
www.rootsanalysis.com/reports/medical-polymers-market.html

You may also be interested in the following titles:
Nanoparticle Formulation Market

Conjugation and Labeling Services Market

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
[email protected]